Key Takeaways
Treat psychiatric certainty as a warning when the evidence is thin
A profession under pressure. Andrew Scull’s history follows psychiatry’s repeated promises to cure severe mental illness, from the nineteenth-century asylum to modern neuroscience. The problem is not that every treatment failed. It is that poor understanding, desperate families, and pressure to act made confident claims easy to accept before benefits and risks were properly tested.
Promises met the wards. Early asylum leaders claimed that 60 to 80 percent of patients could recover. Those figures collapsed under scrutiny, while state hospitals grew to hold more than 150,000 people by 1903 and roughly half a million by 1950. Scull’s central warning is that therapeutic certainty can serve professional status and public convenience as readily as patient welfare.
The book’s historical method makes a useful distinction between a treatment’s promise, its actual effects, and the reasons institutions adopt it. Those are separate questions, though public discussion often collapses them into a single verdict of breakthrough or failure. This approach also resists a tempting opposite error: the fact that psychiatry has repeatedly overclaimed does not make mental illness unreal or treatment pointless. Skepticism is most useful when it demands better evidence without turning into reflexive disbelief.
When cures fail, custody can be recast as biological destiny
From hope to containment. Early asylums were promoted as humane, curative places. As recovery claims faltered and institutions filled, degeneration theory offered a darker explanation: insanity supposedly marked inherited biological inferiority. This theory turned therapeutic failure into an argument for keeping people apart, rather than a reason to question the treatment system.
Ideas became policy. Eugenic beliefs helped justify marriage bans, involuntary sterilization, immigration restrictions, and segregated care for Black patients. In 1927, the US Supreme Court upheld Carrie Buck’s forced sterilization in Buck v. Bell. The theory was not merely mistaken biology. It gave social prejudice a medical vocabulary, while patients with little legal power had few ways to challenge it.
This history shows how diagnostic language can do political work even when its scientific basis is weak. A claim about inherited defect appears to describe individuals, yet it can also authorize restrictions on whole groups. The account is especially important because the targets were not selected by evidence alone: race, class, and gender shaped who was confined, operated on, or denied rights. The broader lesson is to examine who gains authority from a medical explanation, not only whether it sounds scientific.
Demand independent evidence before desperation becomes a treatment protocol
A theory turned invasive. Henry Cotton, superintendent of New Jersey’s Trenton State Hospital, believed hidden infections caused mental illness. He removed teeth and tonsils, then expanded his campaign to organs including colons and reproductive organs. He reported an 85 percent recovery rate, attracting prominent supporters and families seeking hope.
The audit was suppressed. Cotton’s surgeries carried heavy risks. In one reported series, 30 percent of patients who underwent colon operations died. Psychiatrist Phyllis Greenacre’s review found few recoveries and no convincing evidence that the procedures worked, but her report was buried. Cotton’s case illustrates how professional loyalty and patients’ vulnerability can protect a therapy long after its claims deserve scrutiny.
The case highlights a basic safeguard: outcomes should be assessed by people who do not depend on the treatment’s success for their reputation or income. It also shows why testimonials and before-and-after stories are weak evidence. Patients may improve naturally, be selected because they seem likely to improve, or be judged by observers who expect success. Independent review cannot remove uncertainty, but it can expose the difference between a persuasive narrative and a reliable result.
Follow the incentives behind each psychiatric revolution
War widened the field. During the Second World War, psychiatrists treated large numbers of soldiers whose breakdowns followed combat stress, challenging the idea that serious distress belonged only to the biologically defective. After the war, psychoanalytically oriented psychiatrists gained influence and extended their work beyond asylums, though claims that family dynamics caused schizophrenia often blamed mothers without producing reliable cures.
Markets changed the method. Clinical psychologists developed shorter, symptom-focused therapies, including cognitive behavioral therapy, that were easier to evaluate and reimburse than open-ended analysis. Managed care favored these briefer treatments, while psychiatrists increasingly turned to medication. The profession’s shifts reflected not only new ideas, but also training systems, insurance rules, and competition among occupations.
A history of professional change becomes clearer when intellectual arguments are read alongside the institutions that reward them. A therapy may spread because it fits a payment system, a training pipeline, or a new labor market, not simply because evidence has settled the question. That does not make the therapy worthless. It does mean that popularity and efficacy should not be treated as synonyms, especially when a profession’s status and income are tied to a particular model of care.
Do not mistake deinstitutionalization for community care
The numbers fell sharply. US state mental hospital populations peaked at 558,922 in 1955, then dropped to 132,164 by 1980. New drugs helped calm some patients, but they do not explain the timing or scale of the decline: some states’ populations had begun falling before antipsychotics appeared, and studies found no simple link between drug use and faster discharge.
Policy moved the costs. Medicare, Medicaid, and disability benefits made it financially advantageous for states to move patients elsewhere. Many elderly people went to nursing homes; others went to poorly supervised boarding homes, families, streets, or jails. The promise of community care often lacked the housing and services that would make community living viable.
The distinction between closing an institution and building a care system is crucial. A reduction in hospital census can look like successful reform in administrative data while concealing where people actually live and what support they receive. This is a general problem in policy evaluation: the measured outcome may improve because responsibility has shifted, not because the underlying need has been met. The history argues for tracking patients’ living conditions, not just institutional capacity.
A diagnosis can be consistent without naming a real disease
Agreement is not truth. Reliability means clinicians give the same diagnosis to the same case. Validity means the diagnosis corresponds to a distinct condition in nature. US and British psychiatrists often labeled similar patients differently: New York psychiatrists diagnosed schizophrenia in about 62 percent of cases, compared with 34 percent in London. DSM III, published in 1980, used symptom checklists to improve agreement, not to prove that each category was biologically distinct.
A famous warning has limits. David Rosenhan claimed that healthy volunteers were admitted to hospitals after reporting voices. His 1973 paper intensified doubts about diagnosis, but later investigation found serious distortions and probable fabrication in his account. The stronger case for diagnostic uncertainty comes from broader studies, not from treating Rosenhan’s experiment as dependable evidence.
Reliability and validity are different achievements, and the distinction matters well beyond psychiatry. A consistent classification can still carve nature at the wrong joints, particularly when categories are built from overlapping symptoms. Yet criticism should be proportionate: exposing flaws in Rosenhan’s study does not erase documented disagreements among clinicians. The careful position is neither that diagnoses are objective facts nor that they are meaningless labels. They are working tools whose usefulness depends on what they predict and support.
Medication can relieve symptoms without proving a chemical cause
The first revolution was accidental. Chlorpromazine, marketed in the United States as Thorazine, was developed for other medical uses. Clinicians noticed that it calmed psychiatric patients, and within eighteen months of its US launch, two million people had received it. It could reduce agitation and psychotic symptoms, but it did not cure everyone, address many disabling symptoms, or establish that schizophrenia was caused by a chemical imbalance.
Benefits carry costs. In the CATIE study, a major comparison of antipsychotics, about 74 percent of participants stopped their assigned medication, often because it did not help or side effects were intolerable. Antidepressants also outperform placebos on average, but the added improvement is modest for many patients. Drugs can provide valuable relief, while their marketing claims and biological explanations remain stronger than the evidence warrants.
The key distinction is between a drug changing symptoms and a drug correcting the cause of a disorder. Those claims are often conflated, though a medication can help without validating the theory used to explain why it helps. The same caution applies to side effects: a calmer ward is meaningful, but it is not the same outcome as a patient’s improved agency, relationships, or quality of life. Evaluation should include what patients gain, what they lose, and how long any benefit lasts.
Treat brain, biography, and social conditions as one interacting system
Biology did not deliver a simple map. Twin studies found higher schizophrenia concordance among identical than fraternal twins, but identical twins still often differed. Later genome-wide studies identified many genetic associations, each with small effects. One large study linked 108 genetic locations to schizophrenia, together accounting for about 4 percent of diagnostic variation. Such findings suggest risk, not destiny, and do not reveal a single cause.
The categories remain unsettled. Brain differences in patients may reflect illness, treatment, or both. Scull argues that mental disturbance develops through interactions among biological vulnerability, personal history, and social environment. Treating mind and brain as separate domains obscures how experience and surroundings shape the developing brain, while treating biology as the whole explanation overlooks the conditions in which distress takes form.
This interactionist view avoids the false choice between nature and nurture. It also asks for a more useful kind of evidence: not merely whether a factor correlates with a diagnosis, but how it participates in a person’s course of illness and what intervention follows. The argument does not make biology irrelevant. It makes biological findings more intelligible when linked to development and lived conditions. The remaining challenge is practical: broad explanations are humane, but they must still guide specific decisions.
Fund stable housing and care before calling discharge a cure
Neglect outlasted the asylum. Many people with severe mental illness left hospitals without dependable housing, follow-up, or family support. Others were diverted to boarding homes and nursing facilities that offered little more than food and shelter. Today, jails have become major holding places for people with serious mental illness, while homelessness remains closely tied to unmet care needs.
The burden is unequal. Scull notes that Black Americans are disproportionately represented among people with serious mental illness in jails, against a history of segregated and inferior psychiatric care. People with severe mental illness also face life expectancies roughly 15 to 25 years shorter than the general population. A humane response requires more than medication or discharge: it requires durable public support.
The conclusion shifts the question from where patients should be confined to what conditions allow them to live safely and with dignity. That framing avoids romanticizing the asylum, whose custodial abuses are central to this history, while also refusing to treat abandonment as liberation. Housing, continuity of care, and protection from discrimination are not substitutes for clinical treatment. They are part of the environment in which treatment can succeed or fail.
Analysis
Scull’s argument is not simply that psychiatry has made mistakes. It is that those mistakes recur when uncertainty meets institutional pressure and patients lack power. A proposed cure can solve several problems at once: it may quiet a ward, reassure families, reduce state costs, enhance professional standing, or open a profitable market. These rewards are visible immediately. Durable recovery is harder to define, measure, and deliver. This mismatch helps explain why dramatic interventions can spread on weak evidence and why their harms may be discounted as the price of progress.
The book’s strongest analytical contribution is to connect three histories often told separately: therapeutic experimentation, professional competition, and public policy. Asylum medicine gave way to psychological models, then to diagnostic classification and medication, but each transition also shifted who held authority, which patients counted as worth treating, and where the costs landed. The result is not a smooth march from superstition to science. It is a sequence of changing bargains, some relieving suffering, others transferring it out of sight.
A useful way to read the evidence is to keep three questions separate. Does an intervention reduce a symptom? Does it improve a patient’s functioning and life? Does its theory correctly explain the illness? The book repeatedly shows that success on one question does not settle the others. Thorazine could reduce agitation without proving a chemical cause. A discharge could lower hospital census without creating community care. A diagnostic checklist could improve agreement without identifying natural disease entities.
The account is deliberately skeptical and often strongest on institutional failures. That emphasis is justified by the history presented, but it also means readers should avoid turning critique into a blanket verdict. Some patients benefit from medication or psychotherapy, and symptom relief matters even when cure remains unavailable. The more demanding conclusion is neither faith in each new remedy nor rejection of psychiatry. It is a standard of care that joins cautious evidence, informed attention to patients, and practical support for the social conditions that shape their lives.
Review Summary
Desperate Remedies offers a critical history of psychiatry, detailing its often brutal and ineffective treatments. Reviewers praise Scull's thorough research and engaging writing, while noting the book's depressing content. Many found it eye-opening, particularly regarding the field's ties to pharmaceutical companies and the questionable efficacy of treatments. Some criticize Scull's overwhelmingly negative portrayal, while others appreciate his call for humility in psychiatric practice. Despite its length and heavy subject matter, most reviewers recommend it as an important read for those interested in mental health history.
People Also Read
Glossary
moral treatment
Asylum reform approachA nineteenth-century approach that treated insanity as potentially curable through humane surroundings, regular routines, and nonviolent care. Its advocates promoted purpose-built asylums as therapeutic settings. The early claim that most patients could recover proved far more optimistic than the long-term reality of overcrowded institutions.
degeneration
Inherited decline theoryA historical theory that mental illness and other social problems resulted from inherited biological decline across generations. It recast madness as evidence of inferiority rather than a condition that could affect anyone. The theory helped rationalize confinement, eugenic policies, and discriminatory treatment.
psychobiology
Whole-person psychiatric approachAdolf Meyer’s broad approach to mental illness, which considered biological, psychological, developmental, and social factors in a patient’s life. Meyer encouraged detailed histories and systematic records, including a patient’s physical and social circumstances. The approach was expansive, but it offered few clear rules for deciding which facts mattered most.
focal sepsis
Hidden infection theoryThe theory that chronic, localized infections in places such as the teeth, tonsils, or intestines released toxins that caused disease elsewhere in the body. Psychiatrist Henry Cotton applied it to mental illness and performed extensive extractions and surgeries. His claimed cures were not supported by reliable independent evidence.
PIE
Front-line trauma principlesAn approach to combat-related psychological breakdown emphasizing proximity, immediacy, and expectancy. Soldiers were treated near the front, soon after symptoms appeared, with an expectation that they would return to their units. The method reflected the view that distance from comrades and extended removal from combat could reinforce lasting disability.
DSM III
Symptom-based diagnostic manualThe American Psychiatric Association’s 1980 diagnostic manual, which replaced much psychoanalytic language with operational symptom criteria. Its aim was to make diagnoses more consistent across clinicians and institutions. It did not establish that the categories corresponded to distinct biological diseases, but it reshaped clinical practice, research, and insurance reimbursement.
CATIE
Antipsychotic comparison trialThe Clinical Antipsychotic Trials of Intervention Effectiveness was a large US study comparing several newer antipsychotic drugs with an older medication for chronic schizophrenia. It found limited differences in effectiveness and substantial treatment discontinuation. Participants often stopped because the medication was ineffective or its side effects were difficult to tolerate.
Research Domain Criteria
Biology-led research frameworkA research framework promoted by the National Institute of Mental Health as an alternative to organizing studies around DSM diagnoses. It aimed to investigate dimensions of behavior and brain function rather than assume existing diagnostic categories were biologically valid. The approach remained a research proposal, not a replacement system for clinical diagnosis.
Download PDF
Download EPUB
.epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.